Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells

被引:27
作者
Gorbunova, Elena E. [1 ]
Gavrilovskaya, Irina N. [1 ]
Mackow, Erich R. [1 ]
机构
[1] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA
关键词
Hantavirus; Slit2; Human endothelial cells; Permeability; Inhibition; HANTAVIRUS PULMONARY SYNDROME; GROWTH-FACTOR; HYPOXIA; VEGF; VIRUS; ANGIOPOIETIN-1; PATHOGENESIS; ARGENTINA; DISRUPTS; CADHERIN;
D O I
10.1016/j.antiviral.2013.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hantaviruses nonlytically infect human endothelial cells (ECs) and cause edematous and hemorrhagic diseases. Andes virus (ANDV) causes hantavirus pulmonary syndrome (HPS), and Hantaan virus (HTNV) causes hemorrhagic fever with renal syndrome (HFRS). Hantaviruses enhance vascular endothelial growth factor directed EC permeability resulting in the disassembly of inter-endothelial cell adherens junctions (AJs). Recent studies demonstrate that Slit2 binding to Robo1/Robo4 receptors on ECs has opposing effects on AJ disassembly and vascular fluid barrier functions. Here we demonstrate that Slit2 inhibits ANDV and HTNV induced permeability and AJ disassembly of pulmonary microvascular ECs (PMECs) by interactions with Robo4. In contrast, Slit2 had no effect on the permeability of ANDV infected human umbilical vein ECs (HUVECs). Analysis of Robo1/Robo4 expression determined that PMECs express Robo4, but not Robol, while HUVECs expressed both Robo4 and Robol receptors. SiRNA knockdown of Robo4 in PMECs prevented Slit2 inhibition of ANDV induced permeability demonstrating that Robo4 receptors determine PMEC responsiveness to Slit2. Collectively, this data demonstrates a selective role for Slit2/Robo4 responses within PMECs that inhibits ANDV induced permeability and AJ disassembly. These findings suggest Slit2s utility as a potential HPS therapeutic that stabilizes the pulmonary endothelium and antagonizes ANDV induced pulmonary edema. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 51 条
[1]   Robo4 counteracts VEGF signaling [J].
Acevedo, Lisette M. ;
Weis, Sara M. ;
Cheresh, David A. .
NATURE MEDICINE, 2008, 14 (04) :372-373
[2]   Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema [J].
Berger, MM ;
Hesse, C ;
Dehnert, C ;
Siedler, H ;
Kleinbongard, P ;
Bardenheuer, HJ ;
Kelm, M ;
Bärtsch, P ;
Haefeli, WE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) :763-767
[3]   Pleural fluid characteristics in hantavirus pulmonary syndrome [J].
Bustamante, EA ;
Levy, H ;
Simpson, SQ .
CHEST, 1997, 112 (04) :1133-1136
[4]   Hantavirus cardiopulmonary syndrome [J].
Chang, Betty ;
Crowley, Mark ;
Campen, Matthew ;
Koster, Frederick .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (02) :193-200
[5]   Hypoxia causes permeability oedema in the constant-pressure perfused rat lung [J].
Dehler, M ;
Zessin, E ;
Bärtsch, P ;
Mairbäurl, H .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) :600-606
[6]   The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system [J].
Dickinson, Rachel E. ;
Duncan, W. Colin .
REPRODUCTION, 2010, 139 (04) :697-704
[7]   HANTAVIRUS PULMONARY SYNDROME - A CLINICAL DESCRIPTION OF 17 PATIENTS WITH A NEWLY RECOGNIZED DISEASE [J].
DUCHIN, JS ;
KOSTER, FT ;
PETERS, CJ ;
SIMPSON, GL ;
TEMPEST, B ;
ZAKI, SR ;
KSIAZEK, TG ;
ROLLIN, PE ;
NICHOL, S ;
UMLAND, ET ;
MOOLENAAR, RL ;
REEF, SE ;
NOLTE, KB ;
GALLAHER, MM ;
BUTLER, JC ;
BREIMAN, RF ;
BURKHART, M ;
KALISHMAN, N ;
VOORHEES, R ;
VOORHEES, J ;
SAMUEL, M ;
TANUZ, M ;
HUGHES, L ;
WICTOR, S ;
OTY, G ;
NIMS, L ;
CASTLE, S ;
BRYT, B ;
SEWELL, CM ;
REYNOLDS, P ;
BROWN, T ;
SANDS, L ;
KOMATSU, K ;
KIOSKI, C ;
FLEMING, K ;
DOLL, J ;
LEVY, C ;
FINK, TM ;
MURPHY, P ;
ENGLAND, B ;
SMOLINSKI, M ;
ERICKSON, B ;
SLANTA, W ;
GELLERT, G ;
SCHILLAM, P ;
HOFFMAN, RE ;
LANSER, S ;
NICHOLS, C ;
HUBBARDPOURIER, L ;
CHEEK, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :949-955
[8]   Discovery of vascular permeability factor (VPF) [J].
Dvorak, HF .
EXPERIMENTAL CELL RESEARCH, 2006, 312 (05) :522-526
[9]   DISTRIBUTION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN TUMORS - CONCENTRATION IN TUMOR BLOOD-VESSELS [J].
DVORAK, HF ;
SIOUSSAT, TM ;
BROWN, LF ;
BERSE, B ;
NAGY, JA ;
SOTREL, A ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1275-1278
[10]  
Enria D, 1996, MEDICINA-BUENOS AIRE, V56, P709